Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer.

Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer.

Item
http://www.wikidata.org/entity/Q39953093
DNA Nanotechnology for Cancer TherapyRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingSpecific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicHyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).A versatile polymer micelle drug delivery system for encapsulation and in vivo stabilization of hydrophobic anticancer drugsTargeted polymeric therapeutic nanoparticles: design, development and clinical translation[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.Receptor-targeted nanocarriers for therapeutic delivery to cancer.Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
P2860

Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer.

Item
http://www.wikidata.org/entity/Q39953093
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Bioavailability and therapeuti ...... -overexpressing breast cancer.
@en
Bioavailability and therapeuti ...... -overexpressing breast cancer.
@nl
type
label
Bioavailability and therapeuti ...... -overexpressing breast cancer.
@en
Bioavailability and therapeuti ...... -overexpressing breast cancer.
@nl
prefLabel
Bioavailability and therapeuti ...... -overexpressing breast cancer.
@en
Bioavailability and therapeuti ...... -overexpressing breast cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Bioavailability and therapeuti ...... -overexpressing breast cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921